Magalhães L, Figueiredo M, Cintra F et al (2016) II diretrizes Brasileiras De Fibrilação Atrial. Arquivos brasileiros de cardiologia 106(4). https://doi.org/10.5935/abc.20160055

Virani SS, Alonso A, Aparicio HJ et al (2021) Heart disease and stroke statistics – 2021 update: a report from the American Heart Association. Circulation 143(8):e254–e743. https://doi.org/10.1161/CIR.0000000000000950

Article  PubMed  Google Scholar 

Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S (2011) The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 22(2):349–357. https://doi.org/10.1681/ASN.2010050459

Article  PubMed  PubMed Central  Google Scholar 

Königsbrügge O, Ay C (2019) Atrial fibrillation in patients with end-stage renal disease on hemodialysis: magnitude of the problem and new approach to oral anticoagulation. Res Pract Thromb Haemost 3(4):578–588 Published 2019 Aug 18. https://doi.org/10.1002/rth2.12250

Article  PubMed  PubMed Central  Google Scholar 

Findlay MD, Thomson PC, Fulton RL et al (2015) Risk factors of ischemic stroke and subsequent outcome in patients receiving hemodialysis. Stroke 46(9):2477–2481. https://doi.org/10.1161/STROKEAHA.115.009095

Article  CAS  PubMed  Google Scholar 

January CT, Wann LS, Calkins H et al (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines and the heart rhythm society in collaboration with the Society of thoracic surgeons. Circulation 140(2):e125–e151. https://doi.org/10.1161/CIR.000000000000665

Article  PubMed  Google Scholar 

Van Der Meersch H, De Bacquer D, De Vriese AS (2017) Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis. Am Heart J 184:37–46. https://doi.org/10.1016/j.ahj.2016.09.016

Article  CAS  PubMed  Google Scholar 

Kumar S, Lim E, Covic A et al (2019) Anticoagulation in concomitant chronic kidney Disease and Atrial Fibrillation: JACC Review topic of the Week. J Am Coll Cardiol 74(17):2204–2215. https://doi.org/10.1016/j.jacc.2019.08.1031

Article  CAS  PubMed  Google Scholar 

Deitelzweig S, Bergrath E, di Fusco M et al (2022) Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. Future Cardiol 18(5):393–405. https://doi.org/10.2217/fca-2021-0120

Article  CAS  PubMed  Google Scholar 

Ktenopoulos N, Sagris M, Theofilis P, Lionaki S, Rallidis LS (2022) Direct oral anticoagulants in patients on chronic Dialysis and concomitant Atrial Fibrillation: a Common Clinical Impasse. Front Biosci (Schol Ed) 14(3):21. https://doi.org/10.31083/j.fbs1403021

Article  CAS  PubMed  Google Scholar 

De Vriese AS, Caluwé R, Van Der Meersch H, De Boeck K, De Bacquer D (2021) Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis patients with Atrial Fibrillation: a Multicenter Randomized Controlled Trial. J Am Soc Nephrol 32(6):1474–1483. https://doi.org/10.1681/ASN.2020111566

Article  PubMed  PubMed Central  Google Scholar 

Pokorney SD, Chertow GM, Al-Khalid HR et al (2022) Apixaban for patients with Atrial Fibrillation on hemodialysis: a Multicenter Randomized Controlled Trial. Circulation 146(23):1735–1745. https://doi.org/10.1161/CIRCULATIONAHA.121.054990

Article  PubMed  Google Scholar 

Reinecke H, Engelbertz C, Bauersachs R et al (2023) A randomized controlled trial comparing Apixaban with the Vitamin K Antagonist Phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study. Circulation 147(4):296–309. https://doi.org/10.1161/CIRCULATIONAHA.122.062779

Article  CAS  PubMed  Google Scholar 

Elfar S, Elzeiny SM, Ismail H, Makkeyah Y, Ibrahim M (2022) Direct oral anticoagulants vs. Warfarin in Hemodialysis patients with Atrial Fibrillation: a systematic review and Meta-analysis. Front Cardiovasc Med 9:847286 Published 2022 Jun 9. https://doi.org/10.3389/fcvm.2022.847286

Article  PubMed  PubMed Central  Google Scholar 

Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928. Published 2011 Oct 18

Article  PubMed  PubMed Central  Google Scholar 

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, Available from www.training.cochrane.org/handbook

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. ;372:n71. Published 2021 Mar 29. https://doi.org/10.1136/bmj.n71

Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S (2017) Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst Rev 11(11):CD011373 Published 2017 Nov 6. https://doi.org/10.1002/14651858.CD011373.pub2

Article  PubMed  Google Scholar 

Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365(11):981–992. https://doi.org/10.1056/NEJMoa1107039

Article  CAS  PubMed  Google Scholar 

Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369(22):2093–2104. https://doi.org/10.1056/NEJMoa1310907

Article  CAS  PubMed  Google Scholar 

Connolly SJ, Ezekowitz MD, Yusuf S et al (2010) Dabigatran versus warfarin in patients with atrial fibrillation [published correction appears in N Engl J Med. ;363(19):1877]. N Engl J Med. 2009;361(12):1139–1151. https://doi.org/10.1056/NEJMoa0905561

Faisaluddin M, Alwifati N, Naeem N et al (2023) Safety and efficacy of direct oral anticoagulants Versus Warfarin for Atrial Fibrillation in End-Stage Renal Disease on hemodialysis: a Meta-analysis of Randomized Control trials. Am J Cardiol 206:309–311. https://doi.org/10.1016/j.amjcard.2023.08.116

Article  CAS  PubMed  Google Scholar 

Food and Drug Association (2012) HIGHLIGHTS of PRESCRIBING INFORMATION: Eliquis. FDA/CDER. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202155s000lbl.pdf. Accessed 30 May 2023

Siontis KC, Zhang X, Eckhard A et al (2018) Outcomes Associated with Apixaban Use in patients with end-stage kidney Disease and Atrial Fibrillation in the United States. Circulation 138(15):1519–1529. https://doi.org/10.1161/CIRCULATIONAHA.118.035418

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Vriese AS, Caluwé R, Bailleul E et al (2015) Dose-finding study of rivaroxaban in hemodialysis patients. Am J Kidney Dis 66(1):91–98. https://doi.org/10.1053/j.ajkd.2015.01.022

Article  CAS  PubMed  Google Scholar 

Food and Drug Association (2014) HIGHLIGHTS of PRESCRIBING INFORMATION: Xarelto. FDA/CDER. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022406s015lbl.pdf. Accessed 30 May 2023

Wetmore JB, Weinhandl ED, Yan H et al (2022) Apixaban dosing patterns versus warfarin in patients with nonvalvular atrial fibrillation receiving dialysis: a retrospective cohort study. Am J Kidney Dis S0272–6386(22):00621–00627. https://doi.org/10.1053/j.ajkd.2022.03.007

Article  CAS  Google Scholar 

Kuno T, Takagi H, Ando T et al (2020) Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis [published correction appears in J Am Coll Cardiol. ;75(7):842]. J Am Coll Cardiol. 2020;75(3):273–285. https://doi.org/10.1016/j.jacc.2019.10.059

Malagutte KNDS, Silveira CFSMP, Reis FM et al (2022) Qualidade Da Anticoagulação oral em pacientes com Fibrilação Atrial em um Hospital Terciário no Brasil. Arquivos brasileiros de cardiologia 119(3):363–369. https://doi.org/10.36660/abc.20210805

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quinn LM, Richardson R, Cameron KJ et al (2015) Evaluating time in therapeutic range for hemodialysis patients taking warfarin. Clin Nephrol 83(2):80–85. https://doi.org/10.5414/CN108400

Article  CAS  PubMed  Google Scholar 

Thomson BK, MacRae JM, Barnieh L et al (2011) Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients. BMC Nephrol 12:46. https://doi.org/10.1186/1471-2369-12-46

Article  PubMed  PubMed Central  Google Scholar 

Genovesi S, Rossi E, Gallieni M et al (2015) Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation. Nephrol Dial Transplant 30(3):491–498. https://doi.org/10.1093/ndt/gfu334

Article  CAS  PubMed  Google Scholar